Urine Neutrophil Elastase: A Novel Predictor of ICU Admission for Patients with COVID-19 Infection
Open Access
- 1 April 2025
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 5545-5553
Abstract
Introduction: We aimed to explore the differences of neutrophil elastase (NE) levels between intensive care unit (ICU) and non-ICU patients with COVID-19 infection, as well as its predictive value for COVID-19 progression. Methods: We enrolled the patients admitted with a primary diagnosis of COVID-19. All patients in ICU were diagnosed with the critical type upon admission. Blood was taken within 24 hours, followed by examination of the blood NE level and urine NE level. Other clinical features were recorded. A logistic regression model was used to predict ICU admission. Results: A total of 83 patients were diagnosed, including 52 non-ICU cases and 31 ICU cases. The ICU group showed significantly elevated levels of Neutrophil%, Cr, D-dimer (DD), Procalcitonin (PCT), and C-reactive protein (CRP). Meanwhile, the CD3-cell, T4-cell, and Lymphocyte% levels were lower in the ICU group. Notably, the blood NE levels were similar between groups, whereas the urine NE level was highly significantly higher in the ICU group vs the non-ICU group. After dimension reduction, we constructed a logistic model (UD) using only two factors: the urine NE level and the blood DD level. The overall accuracy of was 86.1%. The urine NE has a strong efficacy in ICU prediction (AUC = 0.893), and the performance of the UD model was even better (AUC = 0.933). Conclusion: Urine NE level is a useful predictor of COVID-19 progression, particularly in patients requiring ICU care. Urine NE has a significantly positive correlation with neutrophil%, DD, and PCT, as well as a negative correlation with lymphocyte levels.Keywords
This publication has 30 references indexed in Scilit:
- Elastase and exacerbation of neutrophil innate immunity are involved in multi‐visceral manifestations of COVID‐19Allergy, 2021
- Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcomeBMC Pulmonary Medicine, 2020
- Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patientsPLOS ONE, 2020
- Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19Journal of Clinical Pharmacy and Therapeutics, 2020
- Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case seriesBMJ, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) DevelopmentPLOS ONE, 2009
- Entry from the Cell Surface of Severe Acute Respiratory Syndrome Coronavirus with Cleaved S Protein as Revealed by Pseudotype Virus Bearing Cleaved S ProteinJournal of Virology, 2008
- Proteases and cystic fibrosisThe International Journal of Biochemistry & Cell Biology, 2008
- Targeting neutrophil elastase in cystic fibrosisExpert Opinion on Therapeutic Targets, 2008